Clinical Trial: A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mesonephric Gynecologic Cancer
Study Type: INTERVENTIONAL
Official Title: Single Arm Phase II Study of Avutometinib (VS-6766) and Defactinib in Advanced or Recurrent Mesonephric Gynecologic Cancer
Brief Summary:
This study will test if Avutometinib (VS-6766) in combination with Defactinib is an effective treatment for advanced or recurrent mesonephric gynecologic cancer.
Read more